JPS55147300A - Novel steroid* 5 alphaareductase inhibitor - Google Patents

Novel steroid* 5 alphaareductase inhibitor

Info

Publication number
JPS55147300A
JPS55147300A JP5716280A JP5716280A JPS55147300A JP S55147300 A JPS55147300 A JP S55147300A JP 5716280 A JP5716280 A JP 5716280A JP 5716280 A JP5716280 A JP 5716280A JP S55147300 A JPS55147300 A JP S55147300A
Authority
JP
Japan
Prior art keywords
alphaareductase
inhibitor
novel steroid
steroid
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP5716280A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6337799B2 (enrdf_load_stackoverflow
Inventor
Aaru Buroomu Toomasu
Daburiyu Metokarufu Burian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richardson Vicks Inc
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of JPS55147300A publication Critical patent/JPS55147300A/ja
Publication of JPS6337799B2 publication Critical patent/JPS6337799B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
JP5716280A 1979-05-02 1980-05-01 Novel steroid* 5 alphaareductase inhibitor Granted JPS55147300A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3535779A 1979-05-02 1979-05-02

Publications (2)

Publication Number Publication Date
JPS55147300A true JPS55147300A (en) 1980-11-17
JPS6337799B2 JPS6337799B2 (enrdf_load_stackoverflow) 1988-07-27

Family

ID=21882177

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5716280A Granted JPS55147300A (en) 1979-05-02 1980-05-01 Novel steroid* 5 alphaareductase inhibitor

Country Status (3)

Country Link
JP (1) JPS55147300A (enrdf_load_stackoverflow)
BE (1) BE883091A (enrdf_load_stackoverflow)
ZA (1) ZA802452B (enrdf_load_stackoverflow)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6479198A (en) * 1987-06-29 1989-03-24 Merck & Co Inc Dehydrogenation and intermediate

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6479198A (en) * 1987-06-29 1989-03-24 Merck & Co Inc Dehydrogenation and intermediate

Also Published As

Publication number Publication date
ZA802452B (en) 1981-04-29
JPS6337799B2 (enrdf_load_stackoverflow) 1988-07-27
BE883091A (fr) 1980-09-01

Similar Documents

Publication Publication Date Title
CS345184A2 (en) Zpusob pripravy n heterocyklyl 4 piperidinaminu
GB2088877B (en) Androstane 17 carbothioates
CS254979A2 (en) Zpusob vyroby 2 pyridylmethylsulfinylbenzimidazolu
CS222779A2 (en) Zpusob pripravy n heterocyklyl 4 piperidinaminu
JPS5615290A (en) 77 and 7788substituted 4*55alphaaepoxymorphinann 66one compound
JPS55118483A (en) 55alkyll22*44cyanophenyl**1*33dioxanes
AU519916B2 (en) 11 beta-substituted steroids
JPS55164626A (en) Corticosteroid composition
ZA801246B (en) Compounds and compositions
JPS5636485A (en) 2*33dihydroo2*6*77trisubstitutedd55 acylbenzofuran
JPS5695198A (en) Ee55*22halogenovinyl**2**deoxycytidines
ZA805646B (en) Compounds and compositions
JPS5645478A (en) 5**aminoalkyll4**44dialkylpsoralen
JPS5645480A (en) 4**substitutedd4*5**88trialkylpsoralen
EG15103A (en) Oxytetrocycline compositions
CS660880A2 (en) Zpusob vyroby 2 substituovanych 4 substituovanych kyselin 5 thiazolkarboxylovych
IE800872L (en) Tickicidal compositions
JPS5697276A (en) Alphaaaryll1hh1*2*44triazolee11ethanols
JPS5699475A (en) 11*88quinolyl**22pyrrolidinone
NZ190832A (en) D-2-azaergoline or 2-aza-(8 or 9)-ergolenes
AU4573079A (en) 2 amino- pyimindones
GB8319141D0 (en) 2 6 6-trimethyl-cyclo-hex-3-en-1-one
NZ193527A (en) Steroid salpha-reductase inhibitors
JPS55127347A (en) 1*1**biphenyll22yllalkylamine derivative
JPS55127385A (en) 9*111dideoxyy100oxaatxb compounds